Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
Oncorus Announces Nomination of ONCR-177, A Next-Generation Oncolytic ...
Oncorus Announces Details of Upcoming ONCR-177 Phase 1
A huge congrats to Ted and the entire Oncorus team on a fantastic ...
Oncorus - Hilco Global
TRIA Completes Design of Oncorus Headquarters | High-Profile Monthly
Oncorus - TotalOffice Interiors
Pitt Biotech Spinout Oncorus Works Toward Clinical Trials
肿瘤免疫治疗平台 Oncorus 完成 5700 万美元 A 轮融资，开发新一代免疫平台-36氪
#immunotherapy #immunooncology | Oncorus
PPF Group | Phase 1 data from Oncorus at SITC shows upside after two doses
Oncorus
Oncorus C-suite out the door—Chutes & Ladders
Cancer startup Oncorus expands to Andover's Innovation Park - Boston ...
Buy Oncorus Stock – ONCR Stock Quote Today & Investment Insights ...
Oncorus Stock Price | ONCR Stock Quote, News, and History | Markets Insider
What You Need to Know About Oncorus - BioSpace
Why Oncorus (ONCR) Stock Surged 326% Despite a Lack of News
Oncorus Inc
Oncorus raises £65.5m funding to advance oncolytic virus therapies
Oncorus Pivots to Scale Up Manufacturing with New GMP Facility - BioSpace
Oncorus Initiates First-in-Human Phase 1 Study of ONCR-177 for the ...
Oncorus operating profit 2022| Statista
Oncorus poaches Moderna cancer executive Ted Ashburn as CEO | Fierce ...
온코러스(ONCR) 신규업데이트(상장폐지예정) 및 회사소개 Oncorus, Inc. Oncorus Inc. : 네이버 블로그
Oncorus — Hereva Project Management
Oncorus Clinical Manufacturing Facility - DECCO
Auction: Assets of Oncorus State of the Art Lab and Bioprocessing ...
Oncorus | LinkedIn
Assets of Oncorus State of the Art Lab and Bioprocessing Equipment ...
So proud to be a part of the Oncorus team and bringing ONCR-177 to ...
Oncorus on LinkedIn: #internationalwomensday2023
State of The Art Bioprocessing & Lab Equipment Formerly of Oncorus ...
Oncorus Email Format
Oncorus Inc Shares Close in on 52-Week Low - Market Mover | Nasdaq
Sale #3 - State of The Art Lab Equipment Formerly of Oncorus | Surplus ...
Oncorus total equity 2022| Statista
Oncorus Taps DPS Group for Clinical Manufacturing Facility - Connect CRE
Thomas Chalberg - Blogspot: Oncorus Named a Fierce 15 Biotech Company ...
Oncorus построит завод по выпуску вирусной иммунотерапии по стандарту GMP
Oncorus | Cleanroom swing doors | Cleanroom sliding doors
Oncorus drops HSV solid tumor prospect, lays off 15% of workforce ...
Oncorus on LinkedIn: #aacr22 #goingviraltobeatcancer
Oncorus Office Photos | Glassdoor
Wise Construction Chosen by Oncorus for Andover Manufacturing Facility ...
Wise Construction remains on track for 33,000 s/f project for Oncorus ...
Oncorus Has ‘Largest IPO’ Out of Any Pitt Spinout – Regenerative ...
Facing bankruptcy, Oncorus lays off 'substantially' all staff
Once promising cancer therapy startup Oncorus to close down
ONCR | Обзор IPO Oncorus | Анализ IPO ONCR PROIPO.PRO
Oncorus raises $61M in Series A - [Jcount.com]
Oncorus - Level Access and Technology Solution
Assets Formerly of Oncorus | LabX.com
DPS Group tapped by Oncorus to design 88,000 s/f GMP facility : NEREJ
DPS Group Tapped by Oncorus to Design GMP Clinical Manufacturing ...
火視全球|Oncorus——利用病毒治療惡性膠質母細胞瘤 - 每日頭條
ONCR Oncorus：公布ONCR-177实体瘤治疗早期数据，股价-45.5%-美股开户
WISE CONSTRUCTION COMPLETES 105,000 SF CGMP FACILITY FOR ONCORUS’ NEW ...
肿瘤免疫治疗公司Oncorus上市：市值3.4亿美元_创事记_新浪科技_新浪网
#oncr #cancer #oncorus #successisouronlyoption #viralimmunotherapy # ...
온코러스(ONCR) 신규업데이트(인력 감축 계획 발표) 및 회사소개 Oncorus, Inc. : 네이버 블로그
Oncorus, Inc. Culture | Comparably
TRIA's design for Oncorus' space focused on establishing a headquarters ...
PHASE ONE OF ONCORUS' TWO-PHASE CLINICAL CGMP EXPANSION IS ON TRACK ...
塞爾基因參投Oncorus公司5700萬美元A輪融資 - 每日頭條
【癌症关注】新锐Oncorus完成新一轮融资，资本猛砸溶瘤病毒-北京东方高圣控股股份有限公司
How Many Oncorus, Inc. (NASDAQ:ONCR) Shares Do Institutions Own? | Nasdaq
“溶瘤病毒免疫+检查点抑制”！Oncorus与默沙东合作开发ONCR-177/Keytruda，治疗多种实体瘤！ - 投资专区 - 生物谷
Thomas Chalberg - Blogspot
曾经的溶瘤病毒 “明星”开掉CEO、COO 裁员清算：Oncorus的出现又离开 - 知乎
MLQ.ai | Stocks
临床阶段生物制药公司：Oncorus, Inc.(ONCR) | 美股之家 - 港股美股开户投资百科全书
Oncorus, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Nat Commun：注射人工合成的RNA病毒，用来治疗癌症，解决溶瘤病毒的局限性-MedSci.cn
Oncorus, three other biotechs got venture funding a year ago. Did it help?
We have zero tolerance for racism, bigotry or prejudice – within our ...
OncorusInc-2021-02-11 | Piper Sandler
Sale #2 - State of The Art Bioprocessing and Lab Equipment Formerly of ...
'RNA 항암신약' 온코러스, “자금난, 청산절차 진행” - 바이오스펙테이터
TRIA's PORTFOLIO: designing for industry-leading brands in and around ...
Tides 速递|Oncorus宣布裁员计划 - 知乎
[BioS]대웅제약, 美온코러스와 mRNA 항암신약 “공동개발” - 이투데이
